Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Principal, Namit Mehta and PwC Strategy& Senior Director, Rohit Harve, on the future of cutting-edge gene and cell therapies. This episode includes:
- Addressing the value and impact of gene cell therapy to improve the quality of life
- Challenges and opportunities with the adoption of a gene cell therapy operating models
- Solutions and emerging technologies health organizations should consider in their approach to deliver gene cell therapies
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
03/23/22 • 18 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/next-in-health-214439/unlocking-the-full-potential-of-cell-and-gene-therapies-24019935"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to unlocking the full potential of cell and gene therapies on goodpods" style="width: 225px" /> </a>
Copy